Carvedilol Tablet, Film Coated
Product Images NDC 68071-4600

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Carvedilol (NDC 68071-4600). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

68071 4600 8

68071 4600 8
This is a label of Carvedilol 6.25mg tablets manufactured by NuCare Pharmaceuticals, Inc. It contains information about the product including the NDC number, lot number, and expiration date. The tablets are oval shaped, white/off-white in color with 'E' on one side and '02' on the other side. The label warns to keep the medicine out of reach of children and store it in a controlled temperature environment. It also instructs to contact a doctor for medical advice about side effects and reports to FDA if any side effects occur.*
FDA Label Image

Figure 1. Survival Analysis For Copernicus (intent-to-treat) (Carvedilol Fig1)

FDA Label Image

Figure 2. Effects On Mortality For Subgroups In Copernicus (Carvedilol Fig2)

Figure 2. Effects On Mortality For Subgroups In Copernicus (Carvedilol Fig2)
This text provides a chart labeled Figure 2 that shows the effects on mortality for different subgroups in COPERNICUS. The subgroups include men, women, age less than 65 or equal to 65, non-black or black, diabetic or non-diabetic, ischemic or non-ischemic, those with a heart rate under 70 or higher, those with a systolic blood pressure (SBP) above 120 mm Hg or under 120 mm Hg, those taking spironolactone or not, and all patients. The chart displays hazard ratios on the y-axis from 0 to 20 and is divided into increments of 5. There is no additional usable information available.*
FDA Label Image

Figure 3. Survival Analysis For Capricorn (intent-to-treat) (Carvedilol Fig3)

FDA Label Image

Figure 4. Effects On Mortality For Subgroups In Capricorn (Carvedilol Fig4)

FDA Label Image

Chemical Structure (Carvedilol Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.